Welcome to our dedicated page for Axalta Coating Sys SEC filings (Ticker: AXTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Axalta Coating Systems Ltd. (AXTA) SEC filings page on Stock Titan aggregates the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. Axalta is incorporated in Bermuda and its ordinary shares trade on the New York Stock Exchange, so its filings provide detailed information about its coatings business, financial performance, governance and significant corporate events.
Among the key documents available are Form 10-K annual reports and Form 10-Q quarterly reports, which describe Axalta’s Performance Coatings and Mobility Coatings segments, risk factors, management’s discussion and analysis, and the non-GAAP metrics that management uses, such as Adjusted EBITDA, Adjusted Diluted EPS, adjusted net income, Free Cash Flow, tax rate (as adjusted) and Adjusted EBIT. These filings help readers understand how Axalta evaluates its operations and capital allocation over time.
Investors can also review Form 8-K current reports, which Axalta uses to disclose material events. Recent 8-K filings include earnings releases for quarterly results and the announcement of a Merger Agreement with Akzo Nobel N.V. for an all-stock merger of equals. Another 8-K describes an amendment to Axalta’s credit agreement that permits the use of borrowings to fund share repurchases, subject to specified conditions. These documents provide official detail on transactions, financing changes and other significant developments.
For those tracking ownership and compensation, Axalta’s SEC filings also include proxy statements and, where applicable, Form 4 insider transaction reports that show purchases, sales or equity awards involving company insiders. Together, these filings offer a structured view of governance, board decisions and executive incentives.
Stock Titan enhances access to these materials with AI-powered summaries that highlight important points from long filings, such as major risk disclosures, segment discussions or key terms of agreements like the Merger Agreement with AkzoNobel. Real-time updates from EDGAR ensure that new AXTA filings, including 10-Ks, 10-Qs, 8-Ks and Form 4s, appear promptly, allowing users to review both the full documents and concise AI explanations in one place.
Axalta Coating Systems Ltd. officer Anthony Massey reported equity transactions tied to vesting restricted stock units. On February 28, 2026, 2,727 and 2,925 restricted stock units were converted into the same number of common shares at $0.00 per share. To cover tax withholding on these vestings, 855 and 1,060 common shares were withheld at $33.41 per share, characterized as tax-withholding dispositions. After these transactions, Massey directly owned 40,328 common shares of Axalta.
Axalta Coating Systems Ltd. executive and 10% owner, the President of Global Industrial Coatings, reported routine equity compensation activity on February 28, 2026. Restricted stock units converted into common shares, and a portion of the resulting shares was withheld to cover taxes.
The filing shows 4,027 common shares and 3,695 common shares acquired through the vesting of prior restricted stock unit grants, with corresponding dispositions of 1,854 shares and 1,697 shares at $33.41 per share for tax withholding. Following these transactions, the executive directly owns 11,261 common shares and 3,695 restricted stock units.
Axalta Coating Systems Ltd. officer Hadi Awada reported multiple equity compensation transactions on February 28, 2026. He exercised and converted 3,580 and 3,695 restricted stock units into common shares, while 1,561 and 1,722 common shares were automatically withheld to cover tax obligations. After these transactions, he directly held 43,663 common shares. Footnotes explain that the restricted stock units convert into common shares one-for-one and relate to prior grants of 10,739 units from February 28, 2023 and 11,085 units from February 28, 2024, each vesting in three equal annual installments.
Axalta Coating Systems Ltd. SVP and CFO Carl Douglas Anderson II reported equity award activity tied to restricted stock units (RSUs). On February 28, 2026, 7,184 RSUs were converted into the same number of common shares at a price of $0.00 per share.
In a related transaction, 3,012 common shares were withheld at $33.41 per share to cover tax obligations arising from the RSU vesting, a tax-withholding disposition rather than an open-market sale. Following these transactions, he directly held 31,253 common shares.
Axalta Coating Systems Ltd. reported 2025 annual results with net sales of $5,117 million, a 3.0% decrease from 2024 as lower volumes, especially in Performance Coatings, outweighed price and currency benefits. Performance Coatings net sales fell 5.2%, while Mobility Coatings grew 1.1%, helped by stronger pricing and mix.
Cost controls were evident: cost of sales declined 3.5%, SG&A fell 5.0%, and other operating charges dropped 32.9%, reflecting lower restructuring costs. Net income was $379 million with an effective tax rate of 30.5%, up from 21.1% due largely to Bermuda’s new 15% corporate income tax.
The company entered a proposed all-stock merger with Akzo Nobel N.V. in November 2025 and continued to adjust its capital structure, including repurchasing 5.3 million shares for $165 million and prepaying $210 million of 2029 Dollar Term Loans. Operating cash flow strengthened to $649 million, and Axalta ended 2025 with $657 million in cash and $770 million of revolver availability.
Axalta Coating Systems reported record 2025 earnings while progressing toward an all‑stock merger of equals with AkzoNobel, expected to close in late 2026 or early 2027 subject to shareholder and regulatory approvals. Full‑year net sales were $5.12 billion, down 3%, but adjusted EBITDA reached a record $1.13 billion with a 22.0% margin, helped by lower operating and variable costs. Adjusted diluted EPS rose 6% to a record $2.49, even as reported diluted EPS slipped 2% to $1.74. Free cash flow increased to $466 million, supporting $230 million of gross debt reduction and $165 million of share repurchases, bringing net leverage down to 2.3x, the lowest in company history. Fourth‑quarter net sales fell 4% and net income declined to $60 million on softer North American volumes and higher taxes, though adjusted EBITDA margin improved to 21.5%. For 2026, Axalta guides to net sales growth in the low‑ to mid‑single digits, adjusted EBITDA of $1.14–$1.17 billion, adjusted EPS of $2.55–$2.70 and free cash flow above $500 million, while targeting approximately $600 million in cost synergies from the planned combination with AkzoNobel.
Barrow Hanley Global Investors, a Delaware LLC, filed a Schedule 13G reporting beneficial ownership of Axalta Coating Systems Ltd common stock. As of December 31, 2025, it reported beneficial ownership of 17,456,984 shares, representing 8.18% of Axalta’s outstanding common stock.
The filer reported sole voting power over 12,322,194 shares and shared voting power over 5,134,790 shares, with sole dispositive power over all 17,456,984 shares. It certified the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of Axalta.
Axalta Coating Systems reported a strong finish to 2025 and outlined its planned merger of equals with AkzoNobel. Q4 net sales were about $1.3 billion with adjusted EBITDA of $272 million and a 21.5% margin, while free cash flow reached a quarterly record. For 2025, Axalta delivered record adjusted EBITDA of $1.128 billion, a 22% margin, adjusted EPS of $2.49 and free cash flow of $466 million, helped by more than $300 million of variable cost reductions and lower fixed expenses. The company paid down roughly $230 million of debt, reducing net leverage to 2.3x, and cut annual interest expense by nearly $30 million. For 2026, Axalta guides to low single-digit revenue growth, adjusted EBITDA of $1.14–$1.17 billion, EPS of $2.55–$2.70 and free cash flow above $500 million, with margin above 22%. Management highlighted ongoing North America softness, destocking in Refinish and weak Industrial demand, but expects improvement in the second half. The planned AkzoNobel merger targets about $600 million of cost synergies and a combined EBITDA margin around 19%–20%, creating a large, diversified performance coatings company listed on the NYSE.
Axalta Coating Systems is moving forward with a proposed all-stock merger of equals with AkzoNobel, aiming to create a premier global coatings company with a larger combined portfolio and greater scale. The companies highlight expectations for improved profitability, sizable cost and revenue synergies, and substantial long-term value creation from the combination.
The deal is not yet complete and remains subject to shareholder approvals, regulatory clearances and other customary closing conditions, with closing targeted for late 2026 or early 2027. Investors are told that full details of the transaction, including securities to be issued by AkzoNobel, will be provided in a Form F-4 registration statement and joint proxy statement/prospectus to be filed with the SEC.
Axalta Coating Systems Ltd. and Akzo Nobel N.V. describe a proposed merger of equals that would create a global coatings leader with a top-tier portfolio across seven key end markets and roughly 100 recognized brands. The companies highlight expected cost synergies of approximately $600 million, which they say underpin significant earnings-per-share accretion for Axalta shareholders, plus anticipated 100–200 basis points of revenue synergies supported by a combined R&D platform. They also point to a planned NYSE-only listing with enhanced liquidity and a stronger financial profile with the potential for robust EBITDA margins and cash generation to support capital allocation priorities. The communication emphasizes that full details will be provided in a forthcoming Form F-4 registration statement and proxy statement/prospectus, and it outlines extensive risk factors and legal and jurisdictional restrictions associated with the proposed transaction.